nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—Tafluprost—PTGS2—bone cancer	0.0145	1	CrCbGaD
Travoprost—Dermatitis atopic—Epirubicin—bone cancer	0.00606	0.00615	CcSEcCtD
Travoprost—Scotoma—Epirubicin—bone cancer	0.00591	0.006	CcSEcCtD
Travoprost—Dermatitis atopic—Doxorubicin—bone cancer	0.00561	0.00569	CcSEcCtD
Travoprost—Scotoma—Doxorubicin—bone cancer	0.00547	0.00555	CcSEcCtD
Travoprost—Dysphonia—Epirubicin—bone cancer	0.00545	0.00553	CcSEcCtD
Travoprost—Skin discolouration—Methotrexate—bone cancer	0.00531	0.00539	CcSEcCtD
Travoprost—Bone disorder—Methotrexate—bone cancer	0.00531	0.00539	CcSEcCtD
Travoprost—Herpes simplex—Methotrexate—bone cancer	0.0052	0.00528	CcSEcCtD
Travoprost—Dysphonia—Doxorubicin—bone cancer	0.00505	0.00512	CcSEcCtD
Travoprost—Bone disorder—Epirubicin—bone cancer	0.00497	0.00504	CcSEcCtD
Travoprost—Skin discolouration—Epirubicin—bone cancer	0.00497	0.00504	CcSEcCtD
Travoprost—Inflammation—Methotrexate—bone cancer	0.00494	0.00502	CcSEcCtD
Travoprost—Lacrimation increased—Epirubicin—bone cancer	0.00487	0.00494	CcSEcCtD
Travoprost—Herpes simplex—Epirubicin—bone cancer	0.00487	0.00494	CcSEcCtD
Travoprost—Conjunctivitis—Cisplatin—bone cancer	0.00475	0.00482	CcSEcCtD
Travoprost—Inflammation—Epirubicin—bone cancer	0.00463	0.00469	CcSEcCtD
Travoprost—Skin discolouration—Doxorubicin—bone cancer	0.0046	0.00466	CcSEcCtD
Travoprost—Bone disorder—Doxorubicin—bone cancer	0.0046	0.00466	CcSEcCtD
Travoprost—Musculoskeletal pain—Epirubicin—bone cancer	0.00454	0.00461	CcSEcCtD
Travoprost—Lacrimation increased—Doxorubicin—bone cancer	0.00451	0.00457	CcSEcCtD
Travoprost—Herpes simplex—Doxorubicin—bone cancer	0.00451	0.00457	CcSEcCtD
Travoprost—Bradycardia—Cisplatin—bone cancer	0.00447	0.00453	CcSEcCtD
Travoprost—Dermatitis contact—Epirubicin—bone cancer	0.00443	0.0045	CcSEcCtD
Travoprost—Urinary tract disorder—Cisplatin—bone cancer	0.00433	0.0044	CcSEcCtD
Travoprost—Connective tissue disorder—Cisplatin—bone cancer	0.00431	0.00438	CcSEcCtD
Travoprost—Urethral disorder—Cisplatin—bone cancer	0.0043	0.00436	CcSEcCtD
Travoprost—Inflammation—Doxorubicin—bone cancer	0.00428	0.00434	CcSEcCtD
Travoprost—Visual impairment—Cisplatin—bone cancer	0.00423	0.00429	CcSEcCtD
Travoprost—Musculoskeletal pain—Doxorubicin—bone cancer	0.0042	0.00426	CcSEcCtD
Travoprost—Dry eye—Epirubicin—bone cancer	0.00414	0.00421	CcSEcCtD
Travoprost—Dermatitis contact—Doxorubicin—bone cancer	0.0041	0.00416	CcSEcCtD
Travoprost—Eye disorder—Cisplatin—bone cancer	0.0041	0.00416	CcSEcCtD
Travoprost—Tinnitus—Cisplatin—bone cancer	0.00409	0.00415	CcSEcCtD
Travoprost—Cardiac disorder—Cisplatin—bone cancer	0.00407	0.00413	CcSEcCtD
Travoprost—Immune system disorder—Cisplatin—bone cancer	0.00396	0.00402	CcSEcCtD
Travoprost—Mediastinal disorder—Cisplatin—bone cancer	0.00395	0.00401	CcSEcCtD
Travoprost—Abnormal vision—Epirubicin—bone cancer	0.00391	0.00397	CcSEcCtD
Travoprost—Dry eye—Doxorubicin—bone cancer	0.00383	0.00389	CcSEcCtD
Travoprost—Erythema—Cisplatin—bone cancer	0.00382	0.00388	CcSEcCtD
Travoprost—Abnormal vision—Doxorubicin—bone cancer	0.00362	0.00367	CcSEcCtD
Travoprost—Eye pain—Epirubicin—bone cancer	0.00361	0.00366	CcSEcCtD
Travoprost—Vision blurred—Cisplatin—bone cancer	0.0036	0.00365	CcSEcCtD
Travoprost—Ill-defined disorder—Cisplatin—bone cancer	0.00354	0.0036	CcSEcCtD
Travoprost—Malaise—Cisplatin—bone cancer	0.00344	0.0035	CcSEcCtD
Travoprost—Eye pain—Doxorubicin—bone cancer	0.00334	0.00339	CcSEcCtD
Travoprost—Myalgia—Cisplatin—bone cancer	0.00325	0.0033	CcSEcCtD
Travoprost—Anxiety—Cisplatin—bone cancer	0.00324	0.00329	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00323	0.00328	CcSEcCtD
Travoprost—Discomfort—Cisplatin—bone cancer	0.00321	0.00326	CcSEcCtD
Travoprost—Oedema—Cisplatin—bone cancer	0.00312	0.00316	CcSEcCtD
Travoprost—Infection—Cisplatin—bone cancer	0.0031	0.00314	CcSEcCtD
Travoprost—Nervous system disorder—Cisplatin—bone cancer	0.00306	0.0031	CcSEcCtD
Travoprost—Tachycardia—Cisplatin—bone cancer	0.00304	0.00309	CcSEcCtD
Travoprost—Skin disorder—Cisplatin—bone cancer	0.00303	0.00307	CcSEcCtD
Travoprost—Asthma—Methotrexate—bone cancer	0.00301	0.00305	CcSEcCtD
Travoprost—Hypotension—Cisplatin—bone cancer	0.00291	0.00296	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00284	0.00288	CcSEcCtD
Travoprost—Influenza—Epirubicin—bone cancer	0.00282	0.00286	CcSEcCtD
Travoprost—Asthma—Epirubicin—bone cancer	0.00282	0.00286	CcSEcCtD
Travoprost—Dysuria—Methotrexate—bone cancer	0.00281	0.00285	CcSEcCtD
Travoprost—Dyspnoea—Cisplatin—bone cancer	0.00278	0.00282	CcSEcCtD
Travoprost—Angina pectoris—Epirubicin—bone cancer	0.00274	0.00278	CcSEcCtD
Travoprost—Bronchitis—Epirubicin—bone cancer	0.00271	0.00275	CcSEcCtD
Travoprost—Gastrointestinal disorder—Cisplatin—bone cancer	0.00269	0.00273	CcSEcCtD
Travoprost—Infestation NOS—Methotrexate—bone cancer	0.00268	0.00272	CcSEcCtD
Travoprost—Infestation—Methotrexate—bone cancer	0.00268	0.00272	CcSEcCtD
Travoprost—Depression—Methotrexate—bone cancer	0.00267	0.00271	CcSEcCtD
Travoprost—Pain—Cisplatin—bone cancer	0.00267	0.00271	CcSEcCtD
Travoprost—Dysuria—Epirubicin—bone cancer	0.00263	0.00267	CcSEcCtD
Travoprost—Conjunctivitis—Methotrexate—bone cancer	0.00261	0.00265	CcSEcCtD
Travoprost—Asthma—Doxorubicin—bone cancer	0.0026	0.00264	CcSEcCtD
Travoprost—Influenza—Doxorubicin—bone cancer	0.0026	0.00264	CcSEcCtD
Travoprost—Feeling abnormal—Cisplatin—bone cancer	0.00257	0.00261	CcSEcCtD
Travoprost—Angina pectoris—Doxorubicin—bone cancer	0.00254	0.00257	CcSEcCtD
Travoprost—Infestation—Epirubicin—bone cancer	0.00251	0.00255	CcSEcCtD
Travoprost—Infestation NOS—Epirubicin—bone cancer	0.00251	0.00255	CcSEcCtD
Travoprost—Bronchitis—Doxorubicin—bone cancer	0.00251	0.00254	CcSEcCtD
Travoprost—Urinary tract infection—Epirubicin—bone cancer	0.00244	0.00248	CcSEcCtD
Travoprost—Conjunctivitis—Epirubicin—bone cancer	0.00244	0.00248	CcSEcCtD
Travoprost—Dysuria—Doxorubicin—bone cancer	0.00244	0.00247	CcSEcCtD
Travoprost—Pharyngitis—Methotrexate—bone cancer	0.00239	0.00243	CcSEcCtD
Travoprost—Urinary tract disorder—Methotrexate—bone cancer	0.00238	0.00241	CcSEcCtD
Travoprost—Urethral disorder—Methotrexate—bone cancer	0.00236	0.0024	CcSEcCtD
Travoprost—Sinusitis—Epirubicin—bone cancer	0.00236	0.00239	CcSEcCtD
Travoprost—Infestation NOS—Doxorubicin—bone cancer	0.00232	0.00236	CcSEcCtD
Travoprost—Infestation—Doxorubicin—bone cancer	0.00232	0.00236	CcSEcCtD
Travoprost—Visual impairment—Methotrexate—bone cancer	0.00232	0.00235	CcSEcCtD
Travoprost—Hypersensitivity—Cisplatin—bone cancer	0.0023	0.00233	CcSEcCtD
Travoprost—Bradycardia—Epirubicin—bone cancer	0.00229	0.00233	CcSEcCtD
Travoprost—Rhinitis—Epirubicin—bone cancer	0.00226	0.00229	CcSEcCtD
Travoprost—Urinary tract infection—Doxorubicin—bone cancer	0.00226	0.00229	CcSEcCtD
Travoprost—Conjunctivitis—Doxorubicin—bone cancer	0.00226	0.00229	CcSEcCtD
Travoprost—Eye disorder—Methotrexate—bone cancer	0.00225	0.00228	CcSEcCtD
Travoprost—Tinnitus—Methotrexate—bone cancer	0.00225	0.00228	CcSEcCtD
Travoprost—Asthenia—Cisplatin—bone cancer	0.00224	0.00227	CcSEcCtD
Travoprost—Pharyngitis—Epirubicin—bone cancer	0.00224	0.00227	CcSEcCtD
Travoprost—Cardiac disorder—Methotrexate—bone cancer	0.00223	0.00227	CcSEcCtD
Travoprost—Urinary tract disorder—Epirubicin—bone cancer	0.00223	0.00226	CcSEcCtD
Travoprost—Connective tissue disorder—Epirubicin—bone cancer	0.00221	0.00225	CcSEcCtD
Travoprost—Urethral disorder—Epirubicin—bone cancer	0.00221	0.00224	CcSEcCtD
Travoprost—Angiopathy—Methotrexate—bone cancer	0.00218	0.00222	CcSEcCtD
Travoprost—Sinusitis—Doxorubicin—bone cancer	0.00218	0.00221	CcSEcCtD
Travoprost—Immune system disorder—Methotrexate—bone cancer	0.00217	0.00221	CcSEcCtD
Travoprost—Visual impairment—Epirubicin—bone cancer	0.00217	0.0022	CcSEcCtD
Travoprost—Mediastinal disorder—Methotrexate—bone cancer	0.00217	0.0022	CcSEcCtD
Travoprost—Diarrhoea—Cisplatin—bone cancer	0.00213	0.00216	CcSEcCtD
Travoprost—Bradycardia—Doxorubicin—bone cancer	0.00212	0.00215	CcSEcCtD
Travoprost—Mental disorder—Methotrexate—bone cancer	0.00211	0.00214	CcSEcCtD
Travoprost—Eye disorder—Epirubicin—bone cancer	0.00211	0.00214	CcSEcCtD
Travoprost—Tinnitus—Epirubicin—bone cancer	0.0021	0.00213	CcSEcCtD
Travoprost—Erythema—Methotrexate—bone cancer	0.0021	0.00213	CcSEcCtD
Travoprost—Cardiac disorder—Epirubicin—bone cancer	0.00209	0.00212	CcSEcCtD
Travoprost—Rhinitis—Doxorubicin—bone cancer	0.00209	0.00212	CcSEcCtD
Travoprost—Pharyngitis—Doxorubicin—bone cancer	0.00207	0.0021	CcSEcCtD
Travoprost—Urinary tract disorder—Doxorubicin—bone cancer	0.00206	0.00209	CcSEcCtD
Travoprost—Dysgeusia—Methotrexate—bone cancer	0.00205	0.00208	CcSEcCtD
Travoprost—Connective tissue disorder—Doxorubicin—bone cancer	0.00205	0.00208	CcSEcCtD
Travoprost—Angiopathy—Epirubicin—bone cancer	0.00204	0.00207	CcSEcCtD
Travoprost—Urethral disorder—Doxorubicin—bone cancer	0.00204	0.00207	CcSEcCtD
Travoprost—Immune system disorder—Epirubicin—bone cancer	0.00204	0.00207	CcSEcCtD
Travoprost—Mediastinal disorder—Epirubicin—bone cancer	0.00203	0.00206	CcSEcCtD
Travoprost—Back pain—Methotrexate—bone cancer	0.00203	0.00206	CcSEcCtD
Travoprost—Visual impairment—Doxorubicin—bone cancer	0.00201	0.00204	CcSEcCtD
Travoprost—Vision blurred—Methotrexate—bone cancer	0.00198	0.002	CcSEcCtD
Travoprost—Mental disorder—Epirubicin—bone cancer	0.00197	0.002	CcSEcCtD
Travoprost—Rash—Cisplatin—bone cancer	0.00197	0.00199	CcSEcCtD
Travoprost—Dermatitis—Cisplatin—bone cancer	0.00196	0.00199	CcSEcCtD
Travoprost—Erythema—Epirubicin—bone cancer	0.00196	0.00199	CcSEcCtD
Travoprost—Eye disorder—Doxorubicin—bone cancer	0.00195	0.00198	CcSEcCtD
Travoprost—Ill-defined disorder—Methotrexate—bone cancer	0.00194	0.00197	CcSEcCtD
Travoprost—Tinnitus—Doxorubicin—bone cancer	0.00194	0.00197	CcSEcCtD
Travoprost—Cardiac disorder—Doxorubicin—bone cancer	0.00194	0.00196	CcSEcCtD
Travoprost—Dysgeusia—Epirubicin—bone cancer	0.00192	0.00195	CcSEcCtD
Travoprost—Back pain—Epirubicin—bone cancer	0.0019	0.00193	CcSEcCtD
Travoprost—Angiopathy—Doxorubicin—bone cancer	0.00189	0.00192	CcSEcCtD
Travoprost—Malaise—Methotrexate—bone cancer	0.00189	0.00192	CcSEcCtD
Travoprost—Immune system disorder—Doxorubicin—bone cancer	0.00188	0.00191	CcSEcCtD
Travoprost—Vertigo—Methotrexate—bone cancer	0.00188	0.00191	CcSEcCtD
Travoprost—Mediastinal disorder—Doxorubicin—bone cancer	0.00188	0.00191	CcSEcCtD
Travoprost—Nausea—Cisplatin—bone cancer	0.00185	0.00188	CcSEcCtD
Travoprost—Vision blurred—Epirubicin—bone cancer	0.00185	0.00188	CcSEcCtD
Travoprost—Cough—Methotrexate—bone cancer	0.00183	0.00186	CcSEcCtD
Travoprost—Mental disorder—Doxorubicin—bone cancer	0.00183	0.00185	CcSEcCtD
Travoprost—Ill-defined disorder—Epirubicin—bone cancer	0.00182	0.00185	CcSEcCtD
Travoprost—Erythema—Doxorubicin—bone cancer	0.00182	0.00184	CcSEcCtD
Travoprost—Arthralgia—Methotrexate—bone cancer	0.00178	0.00181	CcSEcCtD
Travoprost—Myalgia—Methotrexate—bone cancer	0.00178	0.00181	CcSEcCtD
Travoprost—Chest pain—Methotrexate—bone cancer	0.00178	0.00181	CcSEcCtD
Travoprost—Dysgeusia—Doxorubicin—bone cancer	0.00178	0.0018	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00177	0.0018	CcSEcCtD
Travoprost—Malaise—Epirubicin—bone cancer	0.00177	0.0018	CcSEcCtD
Travoprost—Discomfort—Methotrexate—bone cancer	0.00176	0.00179	CcSEcCtD
Travoprost—Vertigo—Epirubicin—bone cancer	0.00176	0.00179	CcSEcCtD
Travoprost—Back pain—Doxorubicin—bone cancer	0.00176	0.00178	CcSEcCtD
Travoprost—Palpitations—Epirubicin—bone cancer	0.00173	0.00176	CcSEcCtD
Travoprost—Cough—Epirubicin—bone cancer	0.00171	0.00174	CcSEcCtD
Travoprost—Vision blurred—Doxorubicin—bone cancer	0.00171	0.00174	CcSEcCtD
Travoprost—Infection—Methotrexate—bone cancer	0.0017	0.00172	CcSEcCtD
Travoprost—Hypertension—Epirubicin—bone cancer	0.00169	0.00172	CcSEcCtD
Travoprost—Ill-defined disorder—Doxorubicin—bone cancer	0.00168	0.00171	CcSEcCtD
Travoprost—Nervous system disorder—Methotrexate—bone cancer	0.00168	0.0017	CcSEcCtD
Travoprost—Arthralgia—Epirubicin—bone cancer	0.00167	0.00169	CcSEcCtD
Travoprost—Chest pain—Epirubicin—bone cancer	0.00167	0.00169	CcSEcCtD
Travoprost—Myalgia—Epirubicin—bone cancer	0.00167	0.00169	CcSEcCtD
Travoprost—Anxiety—Epirubicin—bone cancer	0.00166	0.00169	CcSEcCtD
Travoprost—Skin disorder—Methotrexate—bone cancer	0.00166	0.00169	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00166	0.00168	CcSEcCtD
Travoprost—Discomfort—Epirubicin—bone cancer	0.00165	0.00167	CcSEcCtD
Travoprost—Malaise—Doxorubicin—bone cancer	0.00164	0.00166	CcSEcCtD
Travoprost—Dry mouth—Epirubicin—bone cancer	0.00163	0.00166	CcSEcCtD
Travoprost—Vertigo—Doxorubicin—bone cancer	0.00163	0.00165	CcSEcCtD
Travoprost—Palpitations—Doxorubicin—bone cancer	0.0016	0.00163	CcSEcCtD
Travoprost—Oedema—Epirubicin—bone cancer	0.0016	0.00162	CcSEcCtD
Travoprost—Hypotension—Methotrexate—bone cancer	0.0016	0.00162	CcSEcCtD
Travoprost—Infection—Epirubicin—bone cancer	0.00159	0.00161	CcSEcCtD
Travoprost—Cough—Doxorubicin—bone cancer	0.00158	0.00161	CcSEcCtD
Travoprost—Nervous system disorder—Epirubicin—bone cancer	0.00157	0.00159	CcSEcCtD
Travoprost—Hypertension—Doxorubicin—bone cancer	0.00157	0.00159	CcSEcCtD
Travoprost—Tachycardia—Epirubicin—bone cancer	0.00156	0.00159	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00156	0.00158	CcSEcCtD
Travoprost—Skin disorder—Epirubicin—bone cancer	0.00156	0.00158	CcSEcCtD
Travoprost—Arthralgia—Doxorubicin—bone cancer	0.00155	0.00157	CcSEcCtD
Travoprost—Chest pain—Doxorubicin—bone cancer	0.00155	0.00157	CcSEcCtD
Travoprost—Myalgia—Doxorubicin—bone cancer	0.00155	0.00157	CcSEcCtD
Travoprost—Anxiety—Doxorubicin—bone cancer	0.00154	0.00156	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00153	0.00156	CcSEcCtD
Travoprost—Discomfort—Doxorubicin—bone cancer	0.00153	0.00155	CcSEcCtD
Travoprost—Dyspnoea—Methotrexate—bone cancer	0.00153	0.00155	CcSEcCtD
Travoprost—Dry mouth—Doxorubicin—bone cancer	0.00151	0.00153	CcSEcCtD
Travoprost—Dyspepsia—Methotrexate—bone cancer	0.00151	0.00153	CcSEcCtD
Travoprost—Hypotension—Epirubicin—bone cancer	0.0015	0.00152	CcSEcCtD
Travoprost—Oedema—Doxorubicin—bone cancer	0.00148	0.0015	CcSEcCtD
Travoprost—Gastrointestinal disorder—Methotrexate—bone cancer	0.00148	0.0015	CcSEcCtD
Travoprost—Fatigue—Methotrexate—bone cancer	0.00147	0.0015	CcSEcCtD
Travoprost—Infection—Doxorubicin—bone cancer	0.00147	0.00149	CcSEcCtD
Travoprost—Pain—Methotrexate—bone cancer	0.00146	0.00148	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00146	0.00148	CcSEcCtD
Travoprost—Nervous system disorder—Doxorubicin—bone cancer	0.00145	0.00147	CcSEcCtD
Travoprost—Tachycardia—Doxorubicin—bone cancer	0.00145	0.00147	CcSEcCtD
Travoprost—Skin disorder—Doxorubicin—bone cancer	0.00144	0.00146	CcSEcCtD
Travoprost—Dyspnoea—Epirubicin—bone cancer	0.00143	0.00145	CcSEcCtD
Travoprost—Feeling abnormal—Methotrexate—bone cancer	0.00141	0.00143	CcSEcCtD
Travoprost—Dyspepsia—Epirubicin—bone cancer	0.00141	0.00143	CcSEcCtD
Travoprost—Gastrointestinal pain—Methotrexate—bone cancer	0.0014	0.00142	CcSEcCtD
Travoprost—Hypotension—Doxorubicin—bone cancer	0.00138	0.0014	CcSEcCtD
Travoprost—Gastrointestinal disorder—Epirubicin—bone cancer	0.00138	0.0014	CcSEcCtD
Travoprost—Fatigue—Epirubicin—bone cancer	0.00138	0.0014	CcSEcCtD
Travoprost—Pain—Epirubicin—bone cancer	0.00137	0.00139	CcSEcCtD
Travoprost—Constipation—Epirubicin—bone cancer	0.00137	0.00139	CcSEcCtD
Travoprost—Abdominal pain—Methotrexate—bone cancer	0.00135	0.00137	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.00135	0.00137	CcSEcCtD
Travoprost—Dyspnoea—Doxorubicin—bone cancer	0.00132	0.00134	CcSEcCtD
Travoprost—Feeling abnormal—Epirubicin—bone cancer	0.00132	0.00134	CcSEcCtD
Travoprost—Gastrointestinal pain—Epirubicin—bone cancer	0.00131	0.00133	CcSEcCtD
Travoprost—Dyspepsia—Doxorubicin—bone cancer	0.0013	0.00132	CcSEcCtD
Travoprost—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00128	0.0013	CcSEcCtD
Travoprost—Fatigue—Doxorubicin—bone cancer	0.00128	0.0013	CcSEcCtD
Travoprost—Pain—Doxorubicin—bone cancer	0.00127	0.00129	CcSEcCtD
Travoprost—Constipation—Doxorubicin—bone cancer	0.00127	0.00129	CcSEcCtD
Travoprost—Abdominal pain—Epirubicin—bone cancer	0.00127	0.00128	CcSEcCtD
Travoprost—Hypersensitivity—Methotrexate—bone cancer	0.00126	0.00128	CcSEcCtD
Travoprost—Asthenia—Methotrexate—bone cancer	0.00123	0.00125	CcSEcCtD
Travoprost—Feeling abnormal—Doxorubicin—bone cancer	0.00122	0.00124	CcSEcCtD
Travoprost—Gastrointestinal pain—Doxorubicin—bone cancer	0.00121	0.00123	CcSEcCtD
Travoprost—Pruritus—Methotrexate—bone cancer	0.00121	0.00123	CcSEcCtD
Travoprost—Hypersensitivity—Epirubicin—bone cancer	0.00118	0.0012	CcSEcCtD
Travoprost—Abdominal pain—Doxorubicin—bone cancer	0.00117	0.00119	CcSEcCtD
Travoprost—Diarrhoea—Methotrexate—bone cancer	0.00117	0.00119	CcSEcCtD
Travoprost—Asthenia—Epirubicin—bone cancer	0.00115	0.00117	CcSEcCtD
Travoprost—Pruritus—Epirubicin—bone cancer	0.00113	0.00115	CcSEcCtD
Travoprost—Dizziness—Methotrexate—bone cancer	0.00113	0.00115	CcSEcCtD
Travoprost—Diarrhoea—Epirubicin—bone cancer	0.0011	0.00111	CcSEcCtD
Travoprost—Hypersensitivity—Doxorubicin—bone cancer	0.00109	0.00111	CcSEcCtD
Travoprost—Rash—Methotrexate—bone cancer	0.00108	0.00109	CcSEcCtD
Travoprost—Dermatitis—Methotrexate—bone cancer	0.00108	0.00109	CcSEcCtD
Travoprost—Headache—Methotrexate—bone cancer	0.00107	0.00109	CcSEcCtD
Travoprost—Asthenia—Doxorubicin—bone cancer	0.00106	0.00108	CcSEcCtD
Travoprost—Dizziness—Epirubicin—bone cancer	0.00106	0.00107	CcSEcCtD
Travoprost—Pruritus—Doxorubicin—bone cancer	0.00105	0.00106	CcSEcCtD
Travoprost—Nausea—Methotrexate—bone cancer	0.00102	0.00103	CcSEcCtD
Travoprost—Diarrhoea—Doxorubicin—bone cancer	0.00101	0.00103	CcSEcCtD
Travoprost—Rash—Epirubicin—bone cancer	0.00101	0.00102	CcSEcCtD
Travoprost—Dermatitis—Epirubicin—bone cancer	0.00101	0.00102	CcSEcCtD
Travoprost—Headache—Epirubicin—bone cancer	0.001	0.00102	CcSEcCtD
Travoprost—Dizziness—Doxorubicin—bone cancer	0.00098	0.000994	CcSEcCtD
Travoprost—Nausea—Epirubicin—bone cancer	0.000951	0.000965	CcSEcCtD
Travoprost—Rash—Doxorubicin—bone cancer	0.000934	0.000948	CcSEcCtD
Travoprost—Dermatitis—Doxorubicin—bone cancer	0.000933	0.000947	CcSEcCtD
Travoprost—Headache—Doxorubicin—bone cancer	0.000928	0.000942	CcSEcCtD
Travoprost—Nausea—Doxorubicin—bone cancer	0.00088	0.000893	CcSEcCtD
